title: [Bevacizumab therapy for Poems syndrome].
authors.forename: V
authors.initials: V
authors.lastname: Doffoel-Hantz
authors.forename: A
authors.initials: A
authors.lastname: Jaccard
authors.forename: A
authors.initials: A
authors.lastname: Sparsa
authors.forename: S
authors.initials: S
authors.lastname: Girault
authors.forename: J M
authors.initials: JM
authors.lastname: Bonnetblanc
authors.forename: D
authors.initials: D
authors.lastname: Bordessoule
authors.forename: C
authors.initials: C
authors.lastname: Bédane
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008875:Middle Aged; D016878:POEMS Syndrome / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab